Joan Mancuso
@joanmancusombc.bsky.social
#PatientAdvocate living with #metastaticbreastcancer since 2007 (treatment pause since 2020). Always supporting the patient voice. Presenter, panelist and author for #breastcancer.
Pinned
Joan Mancuso
@joanmancusombc.bsky.social
· Jun 26
The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research - npj Breast Cancer
npj Breast Cancer - The MBCRC Advocate Researcher Program (MARP): connecting advocates and researchers as collaborative partners in cancer research
www.nature.com
It is an honor to collaborate with excellent advocates, clinicians and scientists on an ongoing project to develop long-term, bi-directional relationships with early career researchers, and what we learned.
www.nature.com/articles/s41...
www.nature.com/articles/s41...
Reposted by Joan Mancuso
💬 Viewpoint: The proposed federal budget and legislative actions, including the One Big Beautiful Bill Act, threaten health care coverage and prevention programs for patients with #HIV, with over 40% relying on #Medicaid for access.
ja.ma/49DMGMl
ja.ma/49DMGMl
December 1, 2025 at 5:00 PM
💬 Viewpoint: The proposed federal budget and legislative actions, including the One Big Beautiful Bill Act, threaten health care coverage and prevention programs for patients with #HIV, with over 40% relying on #Medicaid for access.
ja.ma/49DMGMl
ja.ma/49DMGMl
Reposted by Joan Mancuso
Federal loan use among US medical students increased from 2008 to 2020 as tuition rose 38%.
The One Big Beautiful Bill Act now caps federal loans and eliminates Graduate PLUS Loans, with greatest impact on low-income and out-of-state students. #MedEd
ja.ma/4rmFOJB
The One Big Beautiful Bill Act now caps federal loans and eliminates Graduate PLUS Loans, with greatest impact on low-income and out-of-state students. #MedEd
ja.ma/4rmFOJB
November 28, 2025 at 1:00 PM
Federal loan use among US medical students increased from 2008 to 2020 as tuition rose 38%.
The One Big Beautiful Bill Act now caps federal loans and eliminates Graduate PLUS Loans, with greatest impact on low-income and out-of-state students. #MedEd
ja.ma/4rmFOJB
The One Big Beautiful Bill Act now caps federal loans and eliminates Graduate PLUS Loans, with greatest impact on low-income and out-of-state students. #MedEd
ja.ma/4rmFOJB
Reposted by Joan Mancuso
New open-access article in Supportive Care in Cancer: Intermittent pneumatic compression devices for the prevention and treatment of breast cancer-related lymphedema—a systematic review and meta-analysis
link.springer.com/article/10.1...
#SuppOnc
link.springer.com/article/10.1...
#SuppOnc
November 28, 2025 at 4:42 PM
New open-access article in Supportive Care in Cancer: Intermittent pneumatic compression devices for the prevention and treatment of breast cancer-related lymphedema—a systematic review and meta-analysis
link.springer.com/article/10.1...
#SuppOnc
link.springer.com/article/10.1...
#SuppOnc
Reposted by Joan Mancuso
In this MASCC Short Talk, Prof. Clifton Thornton discusses highlights from our session on transdisciplinary approaches to supportive care.
Watch now: vimeo.com/1140850519?s...
#SuppOnc
Watch now: vimeo.com/1140850519?s...
#SuppOnc
MASCC Short Talks: Prof. Clifton Thornton
This is "MASCC Short Talks: Prof. Clifton Thornton" by MASCC on Vimeo, the home for high quality videos and the people who love them.
vimeo.com
November 26, 2025 at 4:42 PM
In this MASCC Short Talk, Prof. Clifton Thornton discusses highlights from our session on transdisciplinary approaches to supportive care.
Watch now: vimeo.com/1140850519?s...
#SuppOnc
Watch now: vimeo.com/1140850519?s...
#SuppOnc
Reposted by Joan Mancuso
Flu shots aren’t perfect, but they are by far the best way to prevent flu, reduce its severity and avoid complications. That’s why I get the shot every year and make sure my family does as well. If you haven’t gotten this season’s shot yet, make an appointment or talk to your doctor today.
November 26, 2025 at 5:45 PM
Flu shots aren’t perfect, but they are by far the best way to prevent flu, reduce its severity and avoid complications. That’s why I get the shot every year and make sure my family does as well. If you haven’t gotten this season’s shot yet, make an appointment or talk to your doctor today.
Reposted by Joan Mancuso
From innovative treatments to the future of care, Dr. Jill Lacy joins #YaleCancerAnswers to discuss groundbreaking advances against #pancreaticcancer.
#PancreaticCancerAwarenessMonth
▪️ Listen live on WNPR
▪️ Download Apple Podcasts
▪️ Watch on YouTube
#PancreaticCancerAwarenessMonth
▪️ Listen live on WNPR
▪️ Download Apple Podcasts
▪️ Watch on YouTube
November 23, 2025 at 7:37 PM
From innovative treatments to the future of care, Dr. Jill Lacy joins #YaleCancerAnswers to discuss groundbreaking advances against #pancreaticcancer.
#PancreaticCancerAwarenessMonth
▪️ Listen live on WNPR
▪️ Download Apple Podcasts
▪️ Watch on YouTube
#PancreaticCancerAwarenessMonth
▪️ Listen live on WNPR
▪️ Download Apple Podcasts
▪️ Watch on YouTube
Reposted by Joan Mancuso
Pathogenic variants in key cancer susceptibility genes were detected in 5% of US adults in the All of Us study, exceeding prior estimates and highlighting race-based differences in prevalence.
ja.ma/47UCKwD
ja.ma/47UCKwD
November 22, 2025 at 1:00 PM
Pathogenic variants in key cancer susceptibility genes were detected in 5% of US adults in the All of Us study, exceeding prior estimates and highlighting race-based differences in prevalence.
ja.ma/47UCKwD
ja.ma/47UCKwD
Reposted by Joan Mancuso
CAR T-Cell Therapy Shows Early Safety in Recurrent Brain/Leptomeningeal Mets From HER2+ Breast Cancer
@cityofhope.bsky.social @neuroonc.bsky.social #SNO25 #bcsm #oncology www.onclive.com/view/car-t-c...
@cityofhope.bsky.social @neuroonc.bsky.social #SNO25 #bcsm #oncology www.onclive.com/view/car-t-c...
CAR T-Cell Therapy Proves Safe in Recurrent Brain/Leptomeningeal Mets From HER2+ Breast Cancer | OncLive
HER2-directed CAR T-cell therapy was safe in patients with brain/leptomeningeal metastases from HER2-positive breast cancer.
www.onclive.com
November 22, 2025 at 8:47 PM
CAR T-Cell Therapy Shows Early Safety in Recurrent Brain/Leptomeningeal Mets From HER2+ Breast Cancer
@cityofhope.bsky.social @neuroonc.bsky.social #SNO25 #bcsm #oncology www.onclive.com/view/car-t-c...
@cityofhope.bsky.social @neuroonc.bsky.social #SNO25 #bcsm #oncology www.onclive.com/view/car-t-c...
Reposted by Joan Mancuso
New open-access article in Supportive Care in Cancer: From supportive care to strategic intervention: toward a multidisciplinary approach to cutaneous adverse events in cancer treatment
link.springer.com/article/10.1...
#SuppOnc
link.springer.com/article/10.1...
#SuppOnc
November 21, 2025 at 2:44 PM
New open-access article in Supportive Care in Cancer: From supportive care to strategic intervention: toward a multidisciplinary approach to cutaneous adverse events in cancer treatment
link.springer.com/article/10.1...
#SuppOnc
link.springer.com/article/10.1...
#SuppOnc
Reposted by Joan Mancuso
Amid federal funding cuts- and often controversial changes in guidance, 15 state and territorial leaders have come together to create the Governor’s Public Health Alliance.
Here’s what to know about the new coalition.
Here’s what to know about the new coalition.
US Governors Launch Multistate Public Health Coalition
This Medical News article discusses a new state-led coalition, called the Governors Public Health Alliance, to bolster disease detection and response as federal support wanes.
jamanetwork.com
November 21, 2025 at 4:26 PM
Amid federal funding cuts- and often controversial changes in guidance, 15 state and territorial leaders have come together to create the Governor’s Public Health Alliance.
Here’s what to know about the new coalition.
Here’s what to know about the new coalition.
Reposted by Joan Mancuso
How does the tumor microenvironment change as cancer progresses - & which cells appear, persist, or disappear along the way?
Excited to share our new study on the #TME answering this question!
Great collaboration with the Hausser lab 🧪🧬🔬
Open access link: www.cell.com/iscience/ful...
Read more ⏬
Excited to share our new study on the #TME answering this question!
Great collaboration with the Hausser lab 🧪🧬🔬
Open access link: www.cell.com/iscience/ful...
Read more ⏬
Study reveals dynamics of breast tumor microenvironment over time | Johanna Joyce posted on the topic | LinkedIn
How does the tumor microenvironment change as cancer progresses — and which cells appear, persist, or disappear along the way?
In this new study, a wonderful collaboration with Jean Hausser and his l...
www.linkedin.com
November 10, 2025 at 3:06 PM
How does the tumor microenvironment change as cancer progresses - & which cells appear, persist, or disappear along the way?
Excited to share our new study on the #TME answering this question!
Great collaboration with the Hausser lab 🧪🧬🔬
Open access link: www.cell.com/iscience/ful...
Read more ⏬
Excited to share our new study on the #TME answering this question!
Great collaboration with the Hausser lab 🧪🧬🔬
Open access link: www.cell.com/iscience/ful...
Read more ⏬
Reposted by Joan Mancuso
In the wake of a cancer diagnosis, the focus is on the patient, but November’s National Family Caregivers Month reminds us to spotlight the caregivers who take notes, sit through long chemo hours, and support loved ones at home through tough treatments. https://bit.ly/3XC9k0a
November 20, 2025 at 2:07 AM
In the wake of a cancer diagnosis, the focus is on the patient, but November’s National Family Caregivers Month reminds us to spotlight the caregivers who take notes, sit through long chemo hours, and support loved ones at home through tough treatments. https://bit.ly/3XC9k0a
Reposted by Joan Mancuso
We talk about survival,
Patients talk about life.
We must learn patients’ language…
Patients talk about life.
We must learn patients’ language…
November 20, 2025 at 4:38 AM
We talk about survival,
Patients talk about life.
We must learn patients’ language…
Patients talk about life.
We must learn patients’ language…
Reposted by Joan Mancuso
For more than two decades, scientists have studied whether vaccines cause autism. The answer has been consistent: there’s no evidence they do.
I compiled a list of 14 studies, covering more than 10 million children, that find no link between vaccines and autism.
I compiled a list of 14 studies, covering more than 10 million children, that find no link between vaccines and autism.
November 20, 2025 at 9:38 PM
For more than two decades, scientists have studied whether vaccines cause autism. The answer has been consistent: there’s no evidence they do.
I compiled a list of 14 studies, covering more than 10 million children, that find no link between vaccines and autism.
I compiled a list of 14 studies, covering more than 10 million children, that find no link between vaccines and autism.
Co-expression often leads to immune response evasion.
Co-expression of PD1 and PD-L1 in the tumor cell area, by immune cells, suggests a prognostic role for overall survival in hepatocellular carcinoma - Virchows Archiv
Previous studies have shown that the programmed cell death protein 1 (PD1)/programmed cell death protein ligand 1 (PD-L1) axis regulates immune responses by modulating T-cell activity and maintaining ...
link.springer.com
November 20, 2025 at 4:15 PM
Co-expression often leads to immune response evasion.
Reposted by Joan Mancuso
In this MASCC Short Talk, Prof. Raymond Chan shares some key highlights of the work presented at #MASCC25 around patient navigation. Watch now: vimeo.com/1138959256?s...
#SuppOnc
#SuppOnc
MASCC Short Talks: Prof. Raymond Chan
This is "MASCC Short Talks: Prof. Raymond Chan" by MASCC on Vimeo, the home for high quality videos and the people who love them.
vimeo.com
November 20, 2025 at 3:39 PM
In this MASCC Short Talk, Prof. Raymond Chan shares some key highlights of the work presented at #MASCC25 around patient navigation. Watch now: vimeo.com/1138959256?s...
#SuppOnc
#SuppOnc
Regarding the use of ACT.
Survival outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer patients
AbstractBackground. Neoadjuvant chemotherapy (NACT) has been widely used in breast cancer patients. The aim of the study was to compare survival outcomes b
academic.oup.com
November 20, 2025 at 4:04 PM
Regarding the use of ACT.
Reposted by Joan Mancuso
Meta-analysis: #SGLT2 inhibitors slow kidney decline consistently across CKD severity and albuminuria range, supporting their routine use for kidney health.
#KidneyWK @asnkidney.bsky.social
ja.ma/3JqqaMi
#KidneyWK @asnkidney.bsky.social
ja.ma/3JqqaMi
November 7, 2025 at 11:35 PM
Meta-analysis: #SGLT2 inhibitors slow kidney decline consistently across CKD severity and albuminuria range, supporting their routine use for kidney health.
#KidneyWK @asnkidney.bsky.social
ja.ma/3JqqaMi
#KidneyWK @asnkidney.bsky.social
ja.ma/3JqqaMi
Reposted by Joan Mancuso
🎗️ October is #BreastCancerAwarenessMonth!
💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL
💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL
October 24, 2025 at 6:14 PM
🎗️ October is #BreastCancerAwarenessMonth!
💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL
💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL
Reposted by Joan Mancuso
The Week in Cancer News: Some COVID-19 vaccines may strengthen immunotherapy's effectiveness, an antibody-drug conjugate and an immune checkpoint inhibitor improve survival for patients with bladder cancer, and more. buff.ly/Rt5VfsP
October 24, 2025 at 8:37 PM
The Week in Cancer News: Some COVID-19 vaccines may strengthen immunotherapy's effectiveness, an antibody-drug conjugate and an immune checkpoint inhibitor improve survival for patients with bladder cancer, and more. buff.ly/Rt5VfsP
Reposted by Joan Mancuso
📢 #ACCFIT & #ACCEarlyCareer: Are you passionate about improving CV care in rural communities? Help lead impactful, community-based research & drive progress in ❤️ health. Apply for the Thad & Gerry Waites Rural CV Research Fellowship by Oct. 22! 🔗 bit.ly/473XX5v
#ACCHealthEquity #CardioSky #MedSky
#ACCHealthEquity #CardioSky #MedSky
October 20, 2025 at 5:03 PM
📢 #ACCFIT & #ACCEarlyCareer: Are you passionate about improving CV care in rural communities? Help lead impactful, community-based research & drive progress in ❤️ health. Apply for the Thad & Gerry Waites Rural CV Research Fellowship by Oct. 22! 🔗 bit.ly/473XX5v
#ACCHealthEquity #CardioSky #MedSky
#ACCHealthEquity #CardioSky #MedSky
Reposted by Joan Mancuso
Approximately 5 million adult #Medicaid beneficiaries risk losing coverage due to HR 1's work requirements, with a substantial portion having chronic conditions, particularly among those aged 50 to 64.
ja.ma/4mQpVHW
ja.ma/4mQpVHW
October 7, 2025 at 1:00 PM
Approximately 5 million adult #Medicaid beneficiaries risk losing coverage due to HR 1's work requirements, with a substantial portion having chronic conditions, particularly among those aged 50 to 64.
ja.ma/4mQpVHW
ja.ma/4mQpVHW